Exelixis, Inc. (NASDAQ:EXEL) Receives $26.29 Consensus Price Target from Brokerages

Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the sixteen ratings firms that are covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12 month price objective among […]

Related Keywords

United States ,David Edward Johnson ,Patrickj Haley ,William Blair ,Fisher Asset Management ,Exelixis Inc ,Fifth Third Bancorp ,Barclays ,Rise Advisors ,Securities Exchange Commission ,Third Bancorp ,Contravisory Investment Management Inc ,Nasdaq ,Get Free Report ,Director David Edward Johnson ,Exchange Commission ,Asset Management ,Investment Management ,Get Free ,Exelixis Daily ,Exelixis ,Nasdaq Exel ,Rexel ,Medical ,30161q10 ,Ratings ,Consensus ,